Effects of Propofol on Brain Function in Patients With Parkinson's Disease

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
PD - Parkinson's Disease
Interventions
DRUG

Propofol

Propofol was administered using TCI pump induction with a starting target effect concentration of 1.0ug/ml. The target concentration was increased by 0.2-0.5ug/ml if the patient did not reach unconsciousness after 1 min of stabilization of the target concentration. The propofol concentration recorded at this time was the target concentration the patient was induced to unconsciousness. The state of consciousness was tested every 60 s by the investigator, and clinical trial data were collected for 5 min; after that, clinical trial data were recorded before and after induction of anesthesia at 5 min after induction of anesthesia, at intubation and skin dissection, and 1, 3, and 5 min after intubation and skin dissection, respectively.

Trial Locations (1)

Unknown

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER